Economic analyses of human genetics services: a systematic review (Q36296074)

13 August 2017

1 reference

title

Economic analyses of human genetics services: a systematic review (English)

1 reference

13 August 2017

1 reference

3

David L Veenstra

1 reference

13 August 2017

Josh J Carlson

1

1 reference

13 August 2017

Nora Beidler Henrikson

series ordinal

2

1 reference

13 August 2017

Scott D Ramsey

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

519-523

1 reference

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Development and validation of a grading system for the quality of cost-effectiveness studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Cost utility of prenatal diagnosis and the risk-based threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Prenatal screening for cystic fibrosis carriers: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Will genetic testing alter the management of disease caused by infectious agents? A cost-effectiveness analysis of gene-testing strategies for prevention of rheumatic Fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Cost-benefit analysis of universal tandem mass spectrometry for newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.GIM.0000182467.79495.E2

10.1097/01.GIM.0000182467.79495.E2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1027549393

0 references

1 reference